|
US2167480A
(en)
|
1927-11-02 |
1939-07-25 |
Rca Corp |
Signaling
|
|
US4703004A
(en)
|
1984-01-24 |
1987-10-27 |
Immunex Corporation |
Synthesis of protein with an identification peptide
|
|
JPS6440808A
(en)
|
1987-08-05 |
1989-02-13 |
Canon Kk |
Zoom lens
|
|
US6214804B1
(en)
|
1989-03-21 |
2001-04-10 |
Vical Incorporated |
Induction of a protective immune response in a mammal by injecting a DNA sequence
|
|
US5703055A
(en)
|
1989-03-21 |
1997-12-30 |
Wisconsin Alumni Research Foundation |
Generation of antibodies through lipid mediated DNA delivery
|
|
US5264618A
(en)
|
1990-04-19 |
1993-11-23 |
Vical, Inc. |
Cationic lipids for intracellular delivery of biologically active molecules
|
|
US6183745B1
(en)
|
1990-12-12 |
2001-02-06 |
The University Of Queensland |
Subunit papilloma virus vaccine and peptides for use therein
|
|
ATE132742T1
(de)
|
1991-08-16 |
1996-01-15 |
Vical Inc |
Zusammensetzung und verfahren zur behandlung von zystischer fibrose
|
|
US6419931B1
(en)
*
|
1991-08-26 |
2002-07-16 |
Epimmune Inc. |
Compositions and methods for eliciting CTL immunity
|
|
JP3738395B2
(ja)
*
|
1991-08-26 |
2006-01-25 |
エピミューン，インコーポレイティド |
Ｈｌａ−制限型ｂ型肝炎ウィルスのｃｔｌエピトープ
|
|
US5283185A
(en)
|
1991-08-28 |
1994-02-01 |
University Of Tennessee Research Corporation |
Method for delivering nucleic acids into cells
|
|
IL105554A
(en)
|
1992-05-05 |
1999-08-17 |
Univ Leiden |
Peptides of human papillomavirus for use in preparations elicit a human T cell response
|
|
WO1993024640A2
(en)
|
1992-06-04 |
1993-12-09 |
The Regents Of The University Of California |
Methods and compositions for in vivo gene therapy
|
|
US7105574B1
(en)
|
1999-03-26 |
2006-09-12 |
Vical Incorporated |
Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines
|
|
US5334761A
(en)
|
1992-08-28 |
1994-08-02 |
Life Technologies, Inc. |
Cationic lipids
|
|
US9266930B1
(en)
|
1993-03-05 |
2016-02-23 |
Epimmune Inc. |
Inducing cellular immune responses to Plasmodium falciparum using peptide and nucleic acid compositions
|
|
JPH09502086A
(ja)
|
1993-08-06 |
1997-03-04 |
サイテル コーポレイション |
完全ｍａｇｅ１遺伝子のクローニング及び特性決定
|
|
AUPM500494A0
(en)
|
1994-04-12 |
1994-05-05 |
Minister For Agriculture & Rural Affairs For The State Of New South Wales, The |
Composition for use in increasing mucosal immunity
|
|
FR2726764B1
(fr)
|
1994-11-14 |
1997-01-31 |
Pasteur Merieux Serums Vacc |
Adjuvant pour composition vaccinale
|
|
US6008202A
(en)
|
1995-01-23 |
1999-12-28 |
University Of Pittsburgh |
Stable lipid-comprising drug delivery complexes and methods for their production
|
|
FR2732895B1
(fr)
|
1995-04-11 |
1997-05-16 |
Pasteur Merieux Serums Vacc |
Utilisation d'un compose amphipathique cationique comme agent de transfection, comme adjuvant de vaccin, ou comme medicament
|
|
JPH11510046A
(ja)
|
1995-07-21 |
1999-09-07 |
ローヌ−プーラン ローラー ファーマシューティカルズ インコーポレイテッド |
アデノ関連ウイルスリポソーム及び樹状細胞をトランスフェクトして特異性免疫を刺激することにおけるそれらの使用
|
|
WO1998000110A1
(en)
|
1996-07-03 |
1998-01-08 |
University Of Pittsburgh |
Emulsion formulations for hydrophilic active agents
|
|
US7288266B2
(en)
|
1996-08-19 |
2007-10-30 |
United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Liposome complexes for increased systemic delivery
|
|
US7001614B2
(en)
|
1996-08-19 |
2006-02-21 |
The United States Of America As Represented By The Department Of Health And Human Services |
Liposome complexes for increased systemic delivery
|
|
US20030229040A1
(en)
|
1997-03-21 |
2003-12-11 |
Georgetown University |
Cationic liposomal delivery system and therapeutic use thereof
|
|
US6977074B2
(en)
|
1997-07-10 |
2005-12-20 |
Mannkind Corporation |
Method of inducing a CTL response
|
|
US20030022854A1
(en)
|
1998-06-25 |
2003-01-30 |
Dow Steven W. |
Vaccines using nucleic acid-lipid complexes
|
|
US6693086B1
(en)
|
1998-06-25 |
2004-02-17 |
National Jewish Medical And Research Center |
Systemic immune activation method using nucleic acid-lipid complexes
|
|
WO2000045849A2
(en)
|
1999-02-05 |
2000-08-10 |
Genzyme Corporation |
Use of cationic lipids to generate anti-tumor immunity
|
|
EP2286792A1
(en)
|
1999-02-26 |
2011-02-23 |
Novartis Vaccines and Diagnostics, Inc. |
Microemulsions with an adsorbent surface, comprising a microdroplet emulsion
|
|
EP1955709B1
(en)
|
1999-03-26 |
2012-03-14 |
Vical Incorporated |
Adjuvant compositions for enhancing immune responses to polynucleotide-based vaccines
|
|
US6852334B1
(en)
|
1999-04-20 |
2005-02-08 |
The University Of British Columbia |
Cationic peg-lipids and methods of use
|
|
EP1173600A2
(en)
|
1999-04-20 |
2002-01-23 |
The University Of British Columbia |
Cationic peg-lipids and methods of use
|
|
US6649170B1
(en)
|
1999-05-12 |
2003-11-18 |
Statens Serum Institut |
Adjuvant combinations for immunization composition and vaccines
|
|
FR2794370B1
(fr)
|
1999-06-03 |
2003-10-17 |
Biovector Therapeutics |
Fragments proteiques polyepitopiques, leur obtention et leurs utilisations notamment en vaccination
|
|
PL210451B1
(pl)
|
1999-06-10 |
2012-01-31 |
Merial Sas |
Szczepionka DNA przeciwko wirusowi nosówki psów (CDV)
|
|
CA2309313A1
(en)
|
1999-08-05 |
2001-02-05 |
Board Of Trustees Of The University Of Arkansas |
Stimulation of the immune response by human dendritic cell manipulation
|
|
EP2100620A1
(en)
|
1999-09-16 |
2009-09-16 |
Eisai Corporation of North America |
Nucleic acids encoding polyepitope polypeptides
|
|
US20030008813A1
(en)
|
1999-12-17 |
2003-01-09 |
Felgner Philip L. |
Intracellular protein delivery compositions and methods of use
|
|
EP1259592A1
(en)
|
2000-01-11 |
2002-11-27 |
Maxygen, Inc. |
Monocyte-derived dendritic cell subsets
|
|
JP2003533181A
(ja)
*
|
2000-02-01 |
2003-11-11 |
ジ・オースティン・リサーチ・インスティテュート |
ムチン−１誘導抗原および免疫療法におけるその使用
|
|
JP2004508012A
(ja)
|
2000-04-20 |
2004-03-18 |
ザ ユニバーシティ オブ ブリティッシュ コロンビア |
エンドソーム膜不安定剤を用いたｓｐｌｐ媒介性トランスフェクションの強化方法
|
|
ES2307568T3
(es)
|
2000-12-08 |
2008-12-01 |
Coley Pharmaceutical Gmbh |
Acidos nucleicos de tipo cpg y metodos de uso de los mismos.
|
|
EP1355628A2
(en)
|
2001-02-01 |
2003-10-29 |
Board of Regents, The University of Texas System |
Stabilised polymeric aerosols for pulmonary gene delivery
|
|
WO2002077012A2
(en)
|
2001-03-23 |
2002-10-03 |
The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services |
Human papilloma virus immunoreative peptides
|
|
FR2824326B1
(fr)
|
2001-05-04 |
2004-03-19 |
Commissariat Energie Atomique |
Melange de peptides issus des proteines e6 et/ou e7 de papillomavirus et leurs applications
|
|
CA2449054C
(en)
|
2001-05-30 |
2011-01-04 |
The Scripps Research Institute |
Integrin targeting liposome for nucleic acid delivery
|
|
EP1409009A1
(en)
*
|
2001-06-15 |
2004-04-21 |
Nordic Vaccine Technology A/S |
Therapeutical vaccination
|
|
DE60238958D1
(de)
|
2001-06-29 |
2011-02-24 |
Chugai Pharmaceutical Co Ltd |
Krebsimpfstoff mit einem Krebs-Antigen auf Grundlage des Produkts aus dem Tumorunterdrückungsgen WT1 und einem kationischen Liposom
|
|
EP2263465A1
(en)
*
|
2001-07-06 |
2010-12-22 |
Sloan-Kettering Institute for Cancer Research |
Polyvalent conjugate vaccine for cancer
|
|
GB0118517D0
(en)
*
|
2001-07-30 |
2001-09-19 |
Mitsubishi Tokyo Pharm Inc |
Compound
|
|
DE60238864D1
(de)
|
2001-11-07 |
2011-02-17 |
Mankind Corp |
Für epitope von antigenen kodierende expressionsvektoren und verfahren zu deren konzeption
|
|
US7598421B2
(en)
|
2002-05-08 |
2009-10-06 |
Ucl Biomedica Plc |
Materials for the delivery of biologically-active material to cells
|
|
EP1519745B1
(en)
|
2002-07-05 |
2006-12-20 |
Lipoxen Technologies Limited |
Method to enhance an immune response of nucleic acid vaccination
|
|
CN101113178A
(zh)
|
2002-08-12 |
2008-01-30 |
昆士兰医学研究所理事会 |
包含辅助t细胞和细胞毒性t淋巴细胞(ctl)表位的新免疫原性脂肽
|
|
US20050031587A1
(en)
|
2002-10-04 |
2005-02-10 |
Yamanouchi Pharmaceutical Co., Ltd. |
Immune response induction method
|
|
AU2003284239B2
(en)
|
2002-10-21 |
2008-08-21 |
Eisai Inc. |
Compositions and methods for treating human papillomavirus-mediated disease
|
|
SE0301109D0
(sv)
|
2003-04-14 |
2003-04-14 |
Mallen Huang |
Nucleotide vaccine composition
|
|
EP1628637A2
(en)
|
2003-05-30 |
2006-03-01 |
Alza Corporation |
Method of pulmonary administration of an agent
|
|
WO2005000889A1
(en)
|
2003-06-05 |
2005-01-06 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Immunogenic peptides for the treatment of prostate and breast cancer
|
|
US7906122B2
(en)
|
2003-06-18 |
2011-03-15 |
Yissum Research Development Company Of The Hebrew University Of Jersusalem |
Sphingoid polyalkylamine conjugates for Hepatitis B virus vaccination
|
|
AU2004246904B2
(en)
|
2003-06-18 |
2010-02-04 |
Biolab Ltd. |
Sphingolipids polyalkylamine conjugates for use in transfection
|
|
US8592197B2
(en)
|
2003-07-11 |
2013-11-26 |
Novavax, Inc. |
Functional influenza virus-like particles (VLPs)
|
|
CA2544240A1
(en)
|
2003-07-22 |
2005-02-17 |
Cytos Biotechnology Ag |
Cpg-packaged liposomes
|
|
EP1670509A4
(en)
|
2003-09-03 |
2007-10-31 |
Dendritherapeutics Inc |
MULTIPLEX VACCINES
|
|
US20050112559A1
(en)
*
|
2003-09-29 |
2005-05-26 |
The Chinese University Of Hong Kong |
Compositions and methods for diagnosing and preventing severe acute respiratory syndrome (SARS)
|
|
US7691822B2
(en)
|
2003-12-10 |
2010-04-06 |
Canji, Inc. |
Methods and compositions for treatment of interferon-resistant tumors
|
|
CN1559607A
(zh)
|
2004-02-20 |
2005-01-05 |
�й�ũҵ��ѧ |
一种核酸物质与蛋白质类组合物及其生产方法和在免疫调节中的应用
|
|
JP5393978B2
(ja)
|
2004-04-05 |
2014-01-22 |
ゾエティス・ピー・エルエルシー |
マイクロ流動化された水中油型乳剤及びワクチン組成物
|
|
GB0716992D0
(en)
|
2007-08-31 |
2007-10-10 |
Immune Targeting Systems Its L |
Influenza antigen delivery vectors and constructs
|
|
US7303881B2
(en)
|
2004-04-30 |
2007-12-04 |
Pds Biotechnology Corporation |
Antigen delivery compositions and methods of use
|
|
WO2005120152A2
(en)
|
2004-06-07 |
2005-12-22 |
Protiva Biotherapeutics, Inc. |
Cationic lipids and methods of use
|
|
RU2007103343A
(ru)
*
|
2004-06-30 |
2008-08-10 |
АйДи БАЙОМЕДИКАЛ КОРПОРЕЙШН ОФ КВЕБЕК (CA) |
Вакцинная композиция и способы лечения коронавирусной инфекции
|
|
WO2006007712A1
(en)
|
2004-07-19 |
2006-01-26 |
Protiva Biotherapeutics, Inc. |
Methods comprising polyethylene glycol-lipid conjugates for delivery of therapeutic agents
|
|
DE102004057303A1
(de)
*
|
2004-11-26 |
2006-06-01 |
Merck Patent Gmbh |
Stabile Kristallmodifikationen von DOTAP Chlorid
|
|
NZ554710A
(en)
|
2004-12-13 |
2010-03-26 |
Peplin Research Pty Ltd |
Treatment of solid cancers with angeloyl substituted ingenanes
|
|
US20060159738A1
(en)
*
|
2004-12-14 |
2006-07-20 |
Applera Corporation |
Cationic liposomes and methods of use
|
|
EP1838353A2
(en)
|
2005-01-21 |
2007-10-03 |
Introgen Therapeutics, Inc. |
Topical administration permitting prolonged exposure of target cells to therapeutic and prophylactic nucleic acids
|
|
RU2007138027A
(ru)
|
2005-03-14 |
2009-04-20 |
Борд Оф Риджентс Оф Дзе Юниверсити Оф Техас Систем (Us) |
Биоактивные пептиды fus-1 и комплексы полипептидов с наночастицами
|
|
WO2006097099A1
(en)
|
2005-03-18 |
2006-09-21 |
Widex A/S |
Remote control system for a hearing aid
|
|
KR20150032915A
(ko)
|
2005-04-08 |
2015-03-30 |
아르고스 쎄라퓨틱스 인코포레이티드 |
수지상 세포 조성물 및 방법
|
|
KR20080052509A
(ko)
|
2005-04-11 |
2008-06-11 |
더 거버먼트 오브 더 유나이티드 스테이츠 오브 아메리카, 애즈 레프리젠티드 바이 더 세크러테리, 디파트먼트 오브 헬쓰 앤드 휴먼 서비시즈, 센터스 포 디지즈 컨트롤 앤드 프리벤션 |
유행성 독감 바이러스에 대한 백신
|
|
US20060275777A1
(en)
|
2005-06-03 |
2006-12-07 |
Waelti Ernst R |
Novel strategies for protein vaccines
|
|
WO2007022152A2
(en)
|
2005-08-15 |
2007-02-22 |
The Research Foundation Of State University Of New York |
Lipid nano particulates containing antigens as cancer vaccines
|
|
US20110305713A1
(en)
|
2005-10-21 |
2011-12-15 |
Medical College Of Georgia Research Institute, Inc |
Methods and compositions to enhance vaccine efficacy by reprogramming regulatory t cells
|
|
AU2006335256B2
(en)
|
2005-11-22 |
2012-10-18 |
Novartis Vaccines And Diagnostics, Inc. |
Norovirus and sapovirus antigens
|
|
US8802419B2
(en)
*
|
2006-03-02 |
2014-08-12 |
University Of Massachusetts |
Modified pathogens for use as vaccines
|
|
JP2007238559A
(ja)
|
2006-03-10 |
2007-09-20 |
Nagoya City Univ |
未成熟樹状細胞活性化剤及びその使用
|
|
CN101426811A
(zh)
|
2006-04-21 |
2009-05-06 |
特朗斯吉恩股份有限公司 |
基于hpv-16的乳头瘤病毒疫苗
|
|
US20080014251A1
(en)
|
2006-07-14 |
2008-01-17 |
Advanced Vascular Dynamics |
Hemostatic compound and its use
|
|
EP1894941A1
(en)
|
2006-09-01 |
2008-03-05 |
Institut Pasteur |
Treatment of cervical carcinoma with a recombinant adenylate cyclase carrying HPV antigens
|
|
US8129184B2
(en)
|
2006-09-26 |
2012-03-06 |
Cedars-Sinai Medical Center |
Cancer stem cell antigen vaccines and methods
|
|
EP2073818A4
(en)
|
2006-10-18 |
2010-09-15 |
Us Gov Health & Human Serv |
IMPROVEMENT OF ILLNESS RESISTANCE TO RNA VIRUS INFECTIONS WITH INTRA-CYCLOPIC ENSURE SENSORS
|
|
KR100817024B1
(ko)
|
2006-11-09 |
2008-03-26 |
재단법인 목암생명공학연구소 |
핵산 또는 약물을 간에 특이적으로 전달하는 복합체 및이를 포함하는 약학적 조성물
|
|
US8877206B2
(en)
|
2007-03-22 |
2014-11-04 |
Pds Biotechnology Corporation |
Stimulation of an immune response by cationic lipids
|
|
CA2688346A1
(en)
|
2007-05-23 |
2008-12-04 |
Vical Incorporated |
Compositions and methods for enhancing immune responses to vaccines
|
|
US7832751B2
(en)
*
|
2007-06-29 |
2010-11-16 |
Harley-Davidson Motor Company Group, Inc. |
Rear fender assembly
|
|
EA019836B1
(ru)
|
2007-11-02 |
2014-06-30 |
Те Джонс Хопкинс Юниверсити |
Композиции многотипных пептидов hpv и способы лечения или предотвращения папилломавирусной инфекции у человека
|
|
AU2009236306B2
(en)
|
2008-04-17 |
2015-04-02 |
Pds Biotechnology Corporation |
Stimulation of an immune response by enantiomers of cationic lipids
|
|
US8389768B2
(en)
|
2008-05-19 |
2013-03-05 |
The University Of North Carolina At Chapel Hill |
Methods and compositions comprising novel cationic lipids
|
|
US20100086584A1
(en)
|
2008-09-18 |
2010-04-08 |
Juvaris Biotherapeutics, Inc. |
VACCINE COMPOSITIONS OF M2e, HA0 AND BM2 MULTIPLE ANTIGENIC PEPTIDES
|
|
WO2010101663A2
(en)
|
2009-03-06 |
2010-09-10 |
Mount Sinai School Of Medicine Of New York University |
Live attenuated influenza virus vaccines comprising microrna response elements
|
|
JP5797190B2
(ja)
|
2009-05-15 |
2015-10-21 |
アイ アール エックス セーラピューティクス， インコーポレイテッド |
ワクチン免疫療法
|
|
WO2011109294A1
(en)
|
2010-03-01 |
2011-09-09 |
Dicerna Pharmaceuticals, Inc. |
Lipid delivery formulations
|
|
MX2012011300A
(es)
|
2010-03-30 |
2012-11-29 |
Sinai School Medicine |
Vacunas del virus de influenza y usos de las mismas.
|
|
US9408914B2
(en)
|
2010-04-28 |
2016-08-09 |
Kyowa Hakko Kirin Co., Ltd. |
Cationic lipid
|
|
US20130028915A1
(en)
|
2011-07-27 |
2013-01-31 |
Baylor Research Institute |
Dendritic cell (dc)-vaccine therapy for pancreatic cancer
|
|
CN110075292A
(zh)
|
2011-09-12 |
2019-08-02 |
Pds生物科技公司 |
微粒疫苗制剂
|
|
EP2638896A1
(en)
|
2012-03-14 |
2013-09-18 |
Bioneer A/S |
Cationic liposomal drug delivery system for specific targeting of human cd14+ monocytes in whole blood
|
|
EP2639299A1
(en)
|
2012-03-16 |
2013-09-18 |
Invectys |
Universal cancer peptides derived from telomerase
|
|
US10286064B2
(en)
|
2012-06-15 |
2019-05-14 |
Pds Biotechnology Corporation |
Cationic lipid vaccine compositions and methods of use
|
|
TWI672149B
(zh)
|
2012-09-21 |
2019-09-21 |
美商Ｐｄｓ生技公司 |
改良之疫苗組成物及使用方法
|
|
JP6678582B2
(ja)
|
2013-08-21 |
2020-04-08 |
キュアバック アーゲー |
肺癌処置のための組成物およびワクチン、組み合わせ、キット
|
|
AU2014340201B2
(en)
|
2013-10-23 |
2019-02-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
HLA-A24 agonist epitopes of MUC1-C oncoprotein and compositions and methods of use
|
|
CN104189897A
(zh)
|
2014-05-21 |
2014-12-10 |
深圳先进技术研究院 |
一种树突状细胞高效负载抗原的制备方法
|
|
AU2016232280B2
(en)
|
2015-03-16 |
2018-05-31 |
Helmholtz Zentrum München-Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh) |
Method of detecting new immunogenic T cell epitopes and isolating new antigen-specific T cell receptors by means of an MHC cell library
|
|
CN105920599B
(zh)
|
2015-09-17 |
2020-02-11 |
武汉生物制品研究所有限责任公司 |
以阳离子脂质体dotap为佐剂的疫苗及其制备方法
|
|
EP4092112A1
(en)
|
2015-11-13 |
2022-11-23 |
PDS Biotechnology Corporation |
Lipids as synthetic vectors to enhance antigen processing and presentation ex-vivo in dendritic cell therapy
|
|
EP3522908A4
(en)
|
2016-10-05 |
2020-06-24 |
PDS Biotechnology Corporation |
INNOVATIVE HPV16 NON-HLA-RESTRICTED T-CELL VACCINES, COMPOSITIONS AND METHODS FOR USE THEREOF
|
|
WO2018067822A1
(en)
|
2016-10-05 |
2018-04-12 |
Pds Biotechnology Corporation |
Methods to alter the tumor microenvironment for effective cancer immunotherapy
|
|
AU2018378588A1
(en)
|
2017-12-05 |
2020-06-25 |
Pds Biotechnology Corporation |
Methods and compositions comprising cationic lipids for stimulating type 1 interferon genes
|
|
CN111217918B
(zh)
*
|
2020-03-04 |
2020-11-10 |
中山大学 |
一种基于2,4-二氧四氢喋啶合酶的新型冠状病毒s蛋白双区域亚单位纳米疫苗
|